dcbalderramo Profile Banner
Domingo Balderramo Profile
Domingo Balderramo

@dcbalderramo

Followers
301
Following
2K
Media
108
Statuses
631

Gastroenterologist, MD, PhD. IBD. Hospital Privado Universitario de Córdoba. Instituto Universitario de Ciencias Biomédicas de Córdoba. Argentina.

Córdoba, Argentina
Joined April 2016
Don't wanna be here? Send us removal request.
@dcbalderramo
Domingo Balderramo
13 hours
RT @nlavellaneda: Estuchando al 1 @fgomollon en su clase introductoria del curso @gadeccu para manejo clinico-quirurgico de EII en @latamcc….
0
4
0
@dcbalderramo
Domingo Balderramo
2 days
RT @nlavellaneda: El primer curso @gadeccu para manejo médico y quirúrgico de pacientes con Crohn y Colitis Ulcerosa en @latamccr comienza….
0
11
0
@dcbalderramo
Domingo Balderramo
8 days
RT @gilkaplan: Once thought to be a condition only seen in Western nations, IBD progression is now found all around the world. Here’s why.….
0
20
0
@dcbalderramo
Domingo Balderramo
11 days
✅ Preferences of IBD patients regarding advanced therapy treatment characteristics in 5 countries 🌎.
0
0
2
@dcbalderramo
Domingo Balderramo
15 days
RT @nlavellaneda: 🔴 ¿Trabajás con pacientes con Enfermedad Inflamatoria Intestinal? Entonces este curso es para vos. 📚 Llega el 1er Curso….
0
11
0
@dcbalderramo
Domingo Balderramo
16 days
RT @ibdseb: Reflections from D1 of TOPCLASS #CD fistula consortium meeting .❇️ Huge unmet need in #IBD .❇️Our therapeutic approaches have r….
0
19
0
@dcbalderramo
Domingo Balderramo
28 days
@gadeccu⁩ presente en el ineteresante módulo de Endoscopia e EII en la Jornada Cuenca del Plata realiza por ⁦@Endiba
Tweet media one
0
0
5
@dcbalderramo
Domingo Balderramo
30 days
Mañana comienza la XV Jornada de Cuenca del Plata en Buenos Aires. Gran programa con excelentes speakers! @Endiba @gadeccu
Tweet media one
Tweet media two
0
0
9
@dcbalderramo
Domingo Balderramo
1 month
Tweet media one
1
5
17
@dcbalderramo
Domingo Balderramo
1 month
RT @ptandonGI: Transitioning to clinical talks in IBD research! Dr. Olivera from @SinaiHealth discussing how to break the therapeutic ceili….
0
3
0
@dcbalderramo
Domingo Balderramo
2 months
RT @nlavellaneda: ¡Atención!.Ya están abiertas las inscripciones para el primer curso virtual en español sobre el manejo médico-quirúrgico….
0
19
0
@dcbalderramo
Domingo Balderramo
2 months
Comorbidities of difficult to treat patients data from LATAM at #DDW2025 in San Diego. Data from 11 countries 🌎
Tweet media one
2
1
22
@dcbalderramo
Domingo Balderramo
2 months
Encuentro de compañeros de residencia del Hospital Clinic en #DDW2025 @Elsa_Sola1 @MoreiraR_Leti
Tweet media one
0
1
10
@dcbalderramo
Domingo Balderramo
2 months
Great presentation by Dr Parigi from Italy at #DDW2025. Patients with CD that use e-cigarettes have worse evolution (surgery is more closer to diagnosis) and a higher recurrence after surgery compared to no-smokers.
Tweet media one
Tweet media two
Tweet media three
0
0
7
@dcbalderramo
Domingo Balderramo
2 months
Interesting presentation by Dr Joseph Windsor on UC/CD ratio according to IBD stage at #DDW2025. Trend towards an UC/CD ratio of 1 in stage 3.
Tweet media one
0
2
9
@dcbalderramo
Domingo Balderramo
2 months
RT @gilkaplan: I want to thank @dataLindsay and @LingJWWindsor co-first authors of the @Nature paper, for their incredible work in synthesi….
0
10
0
@dcbalderramo
Domingo Balderramo
2 months
It has been a great honor to participate in this fantastic project published in @Nature . Thanks to @IBD_GIVES21 @gilkaplan @Siew_C_Ng @pakotze and all the team for the opportunity to contribute with @MtoroMartin from Argentina to this project.
Tweet media one
3
8
29
@dcbalderramo
Domingo Balderramo
2 months
RT @gilkaplan: Open-access @Nature paper from the @IBD_GIVES21 consortium, co-led by @Siew_C_Ng and I, funded by @HelmsleyTrust, and suppor….
0
41
0
@dcbalderramo
Domingo Balderramo
2 months
RT @gilkaplan: @Siew_C_Ng @Nature @HelmsleyTrust @IOIBD1 @CUHKMedicine @IBD_GIVES21 Thank you so much. So excited to be in New York with yo….
0
5
0
@dcbalderramo
Domingo Balderramo
2 months
RT @MtoroMartin: Enorme alegría por participar de este estudio publicado ayer en @Nature . Es el incentivo para seguir recabando datos que….
0
3
0